Clinical Evidence & Research Papers
Regenerative medicine clinical research papers, including studies on common anatomical applications such as hips & knees.
Allogeneic Stem Cell Therapy Service
Quality assured, high concentration Human Umbilical Cord Tissue Mesenchymal Stem Cells (UC MSCs) for medicinal use in the UK.
Rethink surgery, reduce risk
LifePlus Stem Cells provides doctors, prescribers, clinics and manufacturers with commercially viable Allogeneic Stem Cell Medicines in doses of 5 million cells. LifePlus uses the highest quality human umbilical cord-derived mesenchymal stem cells (UC MSCs) to treat a wide range of orthopaedic and aesthetic concerns.
"Allogeneic MSCs have been shown to be safe in thousands of patients receiving cells via different routes and at different doses in hundreds of peer-reviewed publications reporting clinical trials. The immediate availability of high quality allogeneic stem cells allows prescribers to treat more patients quickly and effectively, without the preparation times associated with Autologous treatments."
Professor Ash Mosahebi
World-leading Allogeneic Technology
Using leading biotechnology, together with our partners, LifePlus Stem Cells have the IP and unique methodology to harvest and multiply UC MSC’s into the millions for medicinal use, with a 80% purity.
Manufacturing is performed under strict licencing and regulations, umbilical cord tissue is taken from multiple anonymous UK consenting donors. Cord tissue sourced from multiple donors ensures a greater yield of cells, far more than from a single source. Stem cells are extracted and frozen immediately to ensure their purity, viability and potency. A full certificate of analysis is provided with every dose.
What sets our service apart?
Strict Licencing
Our cord-derived MSCs are acquired and manufactured in accordance with all required guidelines and regulations.
Fully Measured
Through a commitment to quality assurance, our scientists know the exact quality and quantity of cells in each dose.
Analysis Certificates
Our allogeneic stem cells are processed under an MHRA licence so they can be used in the clinic of any prescriber.
Stringent Processes and Licencing
LifePlus Allogeneic stem cells are processed under an MHRA licence and can, therefore, be delivered by any prescriber at their own clinic. Our unique process is able to multiply UC MSCs into millions.
The quantity and quality of human cord cells is easy to measure, our scientists know the exact quantity and quality of stem cells in every dose approx. 5 million stem cells per dose.
Doctors, private clinics and manufacturers can purchase in vials of 5 million, which can subsequently be split into 2 single doses of 2.5 million. These doses can be administered directly to the patient’s area of concern via site injection or intravenously, depending on the condition and the prescriber.
Allogeneic Treatment Process Example
Need more information? Get in touch
